DuPont de Nemours (DD)
NYSE Market Closed
DuPont de Nemours, Inc. is a global specialty materials and chemicals company whose products are embedded in a wide range of industrial and consumer supply chains. The current business took shape after the breakup of DowDuPont, when the former combined group separated its agriculture and commodity chemicals operations and left DuPont focused on higher-value materials, engineered components, and application-specific technologies.
The company serves markets where performance, reliability, and regulation often matter more than commodity scale. Its materials are used in electronics, semiconductors, circuit boards, medical devices, protective apparel, water filtration, construction products, automotive systems, aerospace applications, and packaging. DuPont’s portfolio includes well-known industrial brands and technologies such as Tyvek protective materials, Nomex and Kevlar aramids, Liveo healthcare materials, FilmTec water membranes, and materials used in advanced electronics manufacturing.
DuPont’s strategy centers on businesses with specialized chemistry, long customer qualification cycles, and technical service requirements. That positioning can support durable customer relationships, particularly in healthcare, water treatment, and electronics, where product consistency and regulatory compliance are important. At the same time, the company remains exposed to cyclical demand in manufacturing, housing, automotive production, and consumer electronics.
For investors, DuPont represents a specialty chemicals stock rather than a broad commodity chemical producer. Its performance is influenced by industrial production trends, semiconductor and electronics capital spending, construction activity, healthcare demand, raw material costs, and portfolio changes through divestitures or separations. The company’s appeal lies in its mix of established materials franchises and exposure to long-term themes such as clean water, medical technology, advanced mobility, and electronic miniaturisation.
Last updated
- Market Cap
- 19.71B
- P/E
- 203.2
- P/FCF
- 19.17
- P/S
- 2.46
- Enterprise Value
- 22.17B
- Sector
- Materials
- Industry
- Plastics Materials, Synthetic Resins, and Nonvulcanizable Elastomers
- Address
- 974 CENTRE ROAD, WILMINGTON, DE, 19805
Resin Market Industry Trends and Global Forecasts 2025-2035: Expanding Use Across Various Industries, Including Aerospace, Electronics, and Medical Devices
Conductive Inks Market Size to Surpass USD 5.86 Billion by 2035 | SNS Insider
Organic Semiconductor Market Size to Worth USD 1175.68 Billion by 2035 | Research by SNS Insider
DuPont rallies after strong results—more upside ahead?
Automotive Aramid Fiber Market worth $1.30 billion by 2030, at a CAGR of 6.8%, says MarketsandMarkets™
Antifog Additives Market Outlook 2026–2031: Expected to Exceed USD 651 Mn by 2031, Led by Asia-Pacific Growth and Supported by Rising Vertical Farming Demand, Says Mordor Intelligence
$9.75 Bn Aramid Fiber Market Industry Trends and Global Forecasts to 2035
[Latest] Global Vacuum Skin Packaging Market Size/Share Worth USD 35.1 Billion by 2035 at a 3.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Chemical Mechanical Planarization Market to Hit $13.23 Billion by 2035 | SNS Insider
Mold Inhibitors Market Size to be Valued at USD 2.20 Billion by 2033 Owing to the Surging Demand for Natural and Clean-Label Preservatives Among Applications Globally
Barrier Coating for Recyclable Flexible Packaging Market Trends Report 2035
Fluoropolymers Market to Reach US$ 12.50 Billion by 2032 | Rising Demand Across Automotive, Aerospace, and Electronics Sectors Says Astute Analytica
High-Performance Films Global Market Research and Forecast Report 2025-2030, Profiles of Major Players - SABIC, Toray Industries Inc., Covestro AG, Solvay, and DuPont
Plastic Compounding Market Size to Worth USD 159.91 Billion by 2035
Black Powder Market Report 2026-2030: Set to Reach $1.31 Billion by 2030 with a 5.4% CAGR
Japan Aramid Fiber Market Projected to Reach US$ 434.99 Million by 2035, Supported by Cross-Border Production Investments Says Astute Analytica
Alginates Market Set to Hit USD 1.11 Billion by 2033, Driven by Rising Demand for Natural and Sustainable Ingredients | SNS Insider
Building Insulation (Glass Wool, Mineral Wool, EPS, XPS, Cellulose, PIR, Phenolic Foam, Polyurethane) Market Trends Analysis and Growth Forecast Report 2025-2033
Textile Dyes Market Research Report: Type, Fiber Type, Source, Application, Countries and Companies Analysis, 2025-2033 | Astute Analytica
Non-Woven Filter Media Market Size to Reach USD 14.32 Billion by 2033 Due to the Rising Need for Quality Filtration Solutions in Different Industries | SNS Insider
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 19.71B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 22.17B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 203.2
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.4
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 2.46
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 13.21
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 2.77
- EPS
- 0.24
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 18.24%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 19.17
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 16.24
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 1.03B
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 0.69%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 0.45%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.23
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 3.1
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 2.43
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.39
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 3.85M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 48.66
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 1.68B | — | 3.07B | 3.26B | 1.61B |
| Gross profit | 602M | — | 1.2B | 1.22B | 543M |
| Operating income | 186M | — | 388M | 373M | 95M |
| EBITDA | 387M | -125M | 591M | 825M | 344M |
| Net income | 161M | — | -123M | 59M | -589M |
| Basic EPS | 0.39 | — | -0.29 | 0.14 | -1.41 |
| Diluted EPS | 0.39 | — | -0.29 | 0.14 | -1.4 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 21.45B | 21.58B | 38.04B | 36.56B | 35.98B |
| Total liabilities | 7.21B | 7.47B | 14.7B | 13.04B | 12.71B |
| Total equity | 14.24B | 14.1B | 23.34B | 23.52B | 23.27B |
| Cash & equivalents | 710M | 715M | 1.96B | 1.84B | 1.76B |
| Current assets | 5.6B | 5.53B | 8.19B | 6.85B | 6.46B |
| Current liabilities | 1.8B | 1.99B | 4.75B | 4.85B | 4.63B |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 153M | 71M | 650M | 340M | 351M |
| Investing cash flow | -108M | -108M | -221M | -111M | -247M |
| Financing cash flow | -47M | -3.02B | 1.54B | -184M | -206M |
| Change in cash | -7M | -3.07B | 1.95B | 76M | -89M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | SD — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 8-K — DuPont de Nemours, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 8-K — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 10-Q — DuPont de Nemours, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Raia Christopher | View Filing | |
| form 4 | Form 4 — Koch Lori | View Filing | |
| form 4 | Form 4 — Hoover Erik T. | View Filing | |
| form 4 | Form 4 — Franzen Antonella B | View Filing | |
| form 4 | Form 4 — BREEN EDWARD D | View Filing | |
| edgar index | SCHEDULE 13G — DuPont de Nemours, Inc. | View Filing | |
| edgar index | DEFA14A — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 8-K — DuPont de Nemours, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — DuPont de Nemours, Inc. | View Filing | |
| edgar index | DEFA14A — DuPont de Nemours, Inc. | View Filing | |
| edgar index | ARS — DuPont de Nemours, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — DuPont de Nemours, Inc. | View Filing | |
| edgar index | PRE 14A — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 8-K — DuPont de Nemours, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — DuPont de Nemours, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| form 4 | Form 4 — Macpherson Donald G | View Filing | |
| form 4 | Form 4 — Lowery Frederick M. | View Filing | |
| form 4 | Form 4 — CUTLER ALEXANDER M | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| form 4 | Form 4 — BREEN EDWARD D | View Filing | |
| form 4 | Form 4 — Raia Christopher | View Filing | |
| form 4 | Form 4 — Abbott Matthew S | View Filing | |
| form 4 | Form 4 — Koch Lori | View Filing | |
| form 4 | Form 4 — Franzen Antonella B | View Filing | |
| form 4 | Form 4 — Bloemhard Jeroen | View Filing | |
| form 4 | Form 4 — Hoover Erik T. | View Filing | |
| form 4 | Form 4 — Raia Christopher | View Filing | |
| form 4 | Form 4 — Barber Madeleine G | View Filing | |
| form 4 | Form 4 — Abbott Matthew S | View Filing | |
| form 4 | Form 4 — Koch Lori | View Filing | |
| form 4 | Form 4 — Ferreira Beth | View Filing | |
| form 4 | Form 4 — Franzen Antonella B | View Filing | |
| form 4 | Form 4 — Bloemhard Jeroen | View Filing | |
| form 4 | Form 4 — Hoover Erik T. | View Filing | |
| form 4 | Form 4 — Macpherson Donald G | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing | |
| edgar index | 4 — DuPont de Nemours, Inc. | View Filing |